Kyn activates the AhR-PCSK9 pathway leading to abnormal lipid metabolism, elevated plasma low-density lipoprotein (LDL-C) levels, and induced ovarian dysfunction, resulting in PCOS-like pathology (Wang et al., 2025). The gene discussed is AHR; the disease is polycystic ovary syndrome.